Literature DB >> 23555173

Case of autoimmune hepatitis with markedly enlarged hepatoduodenal ligament lymph nodes.

Hideki Fujii1, Naoki Ohnishi, Kazuho Shimura, Masafumi Sakamoto, Tohru Ohkawara, Yoshihiko Sawa, Koichi Nishida, Yasuo Ohkawara, Tatsuro Kobata, Kanji Yamaguchi, Yoshito Itoh.   

Abstract

Autoimmune hepatitis (AIH) is a necroinflammatory liver disease of unknown etiology. The disease is characterized histologically by interface hepatitis, biochemically by increased aspartate aminotransferase and alanine aminotransferase levels, and serologically by increased autoantibodies and immunoglobulin G levels. Here we discuss AIH in a previously healthy 37-year-old male with highly elevated serum levels of soluble interleukin-2 receptor and markedly enlarged hepatoduodenal ligament lymph nodes (HLLNs, diameter, 50 mm). Based on these observations, the differential diagnoses were AIH, lymphoma, or Castleman's disease. Liver biopsy revealed the features of interface hepatitis without bridging fibrosis along with plasma cell infiltration which is the typical characteristics of acute AIH. Lymph node biopsy revealed lymphoid follicles with inflammatory lymphocytic infiltration; immunohistochemical examination excluded the presence of lymphoma cells. Thereafter, he was administered corticosteroid therapy: after 2 mo, the enlarged liver reached an almost normal size and the enlarged HLLNs reduced in size. We could not find AIH cases with such enlarged lymph nodes (diameter, 50 mm) in our literature review. Hence, we speculate that markedly enlarged lymph nodes observed in our patient may be caused by a highly activated, humoral immune response in AIH.

Entities:  

Keywords:  Autoimmune hepatitis; Corticosteroid; Hepatoduodenal ligament lymph nodes; Hepatomegaly; Humoral immune response

Mesh:

Substances:

Year:  2013        PMID: 23555173      PMCID: PMC3607761          DOI: 10.3748/wjg.v19.i11.1834

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Diagnosis and management of autoimmune hepatitis.

Authors:  Michael P Manns; Albert J Czaja; James D Gorham; Edward L Krawitt; Giorgina Mieli-Vergani; Diego Vergani; John M Vierling
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

2.  Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C.

Authors:  C F Dietrich; J H Lee; G Herrmann; G Teuber; W K Roth; W F Caspary; S Zeuzem
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

3.  CT diagnosis of 52 patients with lymphoma in abdominal lymph nodes.

Authors:  Ri-Sheng Yu; Wei-Min Zhang; Yi-Qing Liu
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

4.  Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot.

Authors:  B CASTLEMAN; V W TOWNE
Journal:  N Engl J Med       Date:  1954-09-02       Impact factor: 91.245

5.  Abdominal nodal localization of Castleman's disease: report of a case.

Authors:  L G Greco; M Tedeschi; S Stasolla; A Gentile; A Gentile; D Piscitelli
Journal:  Int J Surg       Date:  2010-07-30       Impact factor: 6.071

6.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

7.  Clinical significance of abdominal lymphadenopathy in chronic liver disease.

Authors:  Juan-Angel del Olmo; José-Manuel Esteban; Luis Maldonado; Felicidad Rodríguez; Amparo Escudero; Miguel-Angel Serra; José-Manuel Rodrigo
Journal:  Ultrasound Med Biol       Date:  2002-03       Impact factor: 2.998

8.  Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.

Authors:  Norihiro Nishimoto; Kimio Terao; Toru Mima; Hideko Nakahara; Nobuhiro Takagi; Takahiro Kakehi
Journal:  Blood       Date:  2008-09-10       Impact factor: 22.113

9.  Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.

Authors:  William R Kessler; Oscar W Cummings; George Eckert; Naga Chalasani; Lawrence Lumeng; Paul Y Kwo
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

10.  Expression of interleukin 2 receptors on activated human B cells.

Authors:  T A Waldmann; C K Goldman; R J Robb; J M Depper; W J Leonard; S O Sharrow; K F Bongiovanni; S J Korsmeyer; W C Greene
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  2 in total

1.  The Enlargement of Abdominal Lymph Nodes Is a Characteristic of Autoimmune Liver Disease.

Authors:  Yongjuan Wang; Xiuxiu Xu; Maojuan Ran; Xiaopei Guo; Lu Zhou; Xi Wang; Bangmao Wang; Jie Zhang
Journal:  Mediators Inflamm       Date:  2020-03-21       Impact factor: 4.711

2.  Perihepatic lymphadenopathy in children with chronic viral hepatitis.

Authors:  Katarzyna Gruszczyńska; Jan Baron
Journal:  J Ultrason       Date:  2015-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.